ESR1 and breast carcinoma: In this study, integrating bioinformatics approach with cell biology and pharmacological methods, we demonstrated that mitotane directly bounds ER-α as a direct agonist, inducing cell proliferation of the ER-α positive breast cancer cell line MCF-7 cells.